- Current report filing (8-K)
April 06 2012 - 10:59AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date
of earliest event reported):
March 30, 2012
CHINA SHENGHUO PHARMACEUTICAL HOLDINGS,
INC.
(Exact Name of Registrant as Specified
in Its Charter)
Delaware
(State or Other Jurisdiction
of Incorporation)
001-33537
|
20-2903562
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
No. 2, Jing You Road
|
|
Kunming National Economy &
|
|
Technology Developing District
|
|
People’s Republic of China 650217
|
N/A
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
0086-871-728-2628
(Registrant’s Telephone Number,
Including Area Code)
N/A
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(
see
General Instruction A.2. below):
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Matters.
On April 5, 2012, China Shenghuo Pharmaceutical Holdings,
Inc. (the “Company”) issued a press release announcing that it received an opinion with going concern
qualification from its auditor - Marcum Bernstein & Pinchuk LLP. A copy of such press release is being furnished with
this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01. Financial
Statements and Exhibits.
Exhibit
Number
|
|
Description
|
99.1
|
|
Press Release, dated April 5, 2012
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CHINA SHENGHUO PHARMACEUTICAL HOLDINGS, INC.
|
|
|
Date: April 6, 2012
|
|
|
|
|
By:
|
/s/ Feng Lan
|
|
|
Name: Feng Lan
Title: Chief Executive Officer and President
|
EXHIBIT INDEX
Exhibit
Number
|
|
Description
|
99.1
|
|
Press Release, dated April 5, 2012
|
China Shenghuo Pharmaceutical Holdings, (AMEX:KUN)
Historical Stock Chart
From Apr 2024 to May 2024
China Shenghuo Pharmaceutical Holdings, (AMEX:KUN)
Historical Stock Chart
From May 2023 to May 2024